Is SYGGF or SBUX a better dividend investment in 2026?

SYGGF currently yields 2000000.00% with a 5% 5-year dividend growth rate. SBUX yields 2.75% with 5% growth. The better choice depends on your goal: SYGGF offers higher current income.

What is the dividend yield difference between SYGGF and SBUX?

SYGGF has a forward dividend yield of 2000000.00% ($2.00/share annually). SBUX yields 2.75% ($2.46/share annually). The yield gap is 1999997.25 percentage points.

Home › Compare › SYGGF vs SBUX

SYGGF vs SBUX: Dividend Comparison 2026

SYGGF yields 2000000.00% · SBUX yields 2.75%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SYGGF wins by $4.879226400974806e+39M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SYGGF

● Live price

2000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.879226400974806e+39M

Annual income

$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00

Full SYGGF calculator →

SBUX

● Live price

2.75%

Share price

$89.59

Annual div

$2.46

5Y div CAGR

48.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$157.5K

Annual income

$65,840.13

Full SBUX calculator →

Portfolio growth — SYGGF vs SBUX

📍 SYGGF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SYGGF	SBUX
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SYGGF + SBUX cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SYGGF pays

SBUX pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYGGF

Annual income on $10K today (after 15% tax)

$170,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr

SBUX

Annual income on $10K today (after 15% tax)

$233.40/yr

After 10yr DRIP, annual income (after tax)

$55,964.11/yr

At 15% tax rate, SYGGF beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYGGF + SBUX for your $10,000?

SYGGF: 50%SBUX: 50%

100% SBUX50/50100% SYGGF

Portfolio after 10yr

$2.439613200487403e+39M

Annual income

$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.99%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

SYGGF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

-27.5

Piotroski

1/9

SBUX

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$104.00

+16.1% upside vs current

Range: $90.00 — $120.00

Altman Z

2.6

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYGGF buys

SBUX buys

No recent congressional trades found for SYGGF or SBUX in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSYGGFSBUX

Forward yield	2000000.00% ✓	2.75%
Annual dividend / share	$2.00	$2.46 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	48.3% ✓
Portfolio after 10y	$4.879226400974806e+39M	$157.5K ✓
Annual income after 10y	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00 ✓	$65,840.13
Total dividends collected	$4.879195005460081e+39M	$127.5K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Discretionary
Analyst consensus	Hold	Buy

Year-by-year: SYGGF vs SBUX ($10,000, DRIP)

Year	SYGGF Portfolio	SYGGF Income/yr	SBUX Portfolio	SBUX Income/yr	Gap
1← crossover	$200,010,700	$200,000,000.00	$11,107	$407.21	+$200.00M → SYGGF
2	$3,738,731,768,458	$3,738,517,757,009.35	$12,512	$626.87	+$3738731.76M → SYGGF
3	$65,315,062,866,930,490	$65,311,062,423,938,240.00	$14,366	$978.69	+$65315062866.92M → SYGGF
4	$1,066,400,830,062,625,000,000	$1,066,330,942,945,357,500,000.00	$16,929	$1,557.50	+$1066400830062625.00M → SYGGF
5	$16,272,182,796,453,826,000,000,000	$16,271,041,747,565,660,000,000,000.00	$20,658	$2,543.80	+$16272182796453826560.00M → SYGGF
6	$232,054,240,113,661,900,000,000,000,000	$232,036,828,878,069,680,000,000,000,000.00	$26,406	$4,302.22	+$2.3205424011366188e+23M → SYGGF
7	$3,092,799,066,104,688,500,000,000,000,000,000	$3,092,550,768,067,767,400,000,000,000,000,000.00	$35,877	$7,622.00	+$3.0927990661046884e+27M → SYGGF
8	$38,524,105,697,352,694,000,000,000,000,000,000,000	$38,520,796,402,351,967,000,000,000,000,000,000,000.00	$52,741	$14,352.64	+$3.8524105697352695e+31M → SYGGF
9	$448,468,826,014,798,700,000,000,000,000,000,000,000,000	$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00	$85,676	$29,243.03	+$4.484688260147987e+35M → SYGGF
10	$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000	$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00	$157,513	$65,840.13	+$4.879226400974806e+39M → SYGGF

SYGGF vs SBUX: Complete Analysis 2026

SYGGF — Stock

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.

Full SYGGF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →

📬

Get this SYGGF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYGGF vs SCHD SYGGF vs JEPI SYGGF vs O SYGGF vs KO SYGGF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.